Literature DB >> 6274652

Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle.

K R Courtney.   

Abstract

Mexiletine's actions on voltage-clamped sodium channels of frog myelinated nerve and skeletal muscle are described. Mexiletine blocks half the sodium channels (infrequent depolarizations) of single myelinated nerves at a 83 micro M concentration while only 26 micro M is required to do the same in skeletal muscle preparations where similar vaseline-gap techniques are utilized. Mexiletine's potency for block of sodium current in nerve is clearly related to its lipid distribution characteristics given proper consideration of the drug class to which it belongs. Hyperpolarizing prepulses, which are typically used to remove normal sodium inactivation, appear to reduce drug blocking potency suggesting that noninactive channels have a considerably lower affinity for the drug than do inactive channels. Direct evidence supporting selective drug block of inactive channels is also given. In addition the effects of this drug on sodium channels of guinea pig papillary muscle have been studied using measurements of maximum upstroke velocity of intracellularly recorded action potentials. In these myocardial studies 5 to 20 micro M mexiletine depressed upstroke velocity of papillary muscle action potentials in a frequency-dependent fashion. No basal (nonfrequency-dependent) block was observed in heart at these therapeutic concentrations of mexiletine. comparisons are made between skeletal and cardiac muscle effects of mexiletine, especially relating to the important role played by sodium channel inactivation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274652     DOI: 10.1016/0014-2999(81)90317-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Open-label trial of ranolazine for the treatment of myotonia congenita.

Authors:  W David Arnold; David Kline; Alan Sanderson; Ahmed A Hawash; Amy Bartlett; Kevin R Novak; Mark M Rich; John T Kissel
Journal:  Neurology       Date:  2017-07-14       Impact factor: 9.910

2.  Size-dependent kinetics associated with drug block of sodium current.

Authors:  K R Courtney
Journal:  Biophys J       Date:  1984-01       Impact factor: 4.033

3.  Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels.

Authors:  Stephan A Pless; Jason D Galpin; Adam Frankel; Christopher A Ahern
Journal:  Nat Commun       Date:  2011-06-14       Impact factor: 14.919

4.  Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock.

Authors:  T F McDonald; D Pelzer; W Trautwein
Journal:  J Physiol       Date:  1984-07       Impact factor: 5.182

5.  Use-dependent block of Na+ currents by mexiletine at the single channel level in guinea-pig ventricular myocytes.

Authors:  A Sunami; Z Fan; T Sawanobori; M Hiraoka
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation.

Authors:  G W Zamponi; X Sui; P W Codding; R J French
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

7.  Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres.

Authors:  E Delpón; C Valenzuela; J Tamargo
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

8.  Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons.

Authors:  J Z Yeh; J Tanguy
Journal:  Biophys J       Date:  1985-05       Impact factor: 4.033

9.  Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.

Authors:  G W Zamponi; R J French
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

10.  Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels.

Authors:  M E O'Leary; M Chahine
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.